Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bourin

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Acta Psychiatrica Scandinavica. Supplementum|October 19, 2007
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorderM Berk, S Dodd, M Kauer-Sant'anna, et al.
Acta Psychiatrica Scandinavica. Supplementum|August 18, 2005
A typical mood stabilizers: a "typical role for atypical antipsychoticsG S Malhi, M Berk, M Bourin, et al.
Archives Francaises De Pediatrie|March 1, 1982
[Phenobarbital in the newborn (author's transl)]D Alix, C Riche, Y Guedes, et al.
European Journal of Pharmacology|November 10, 1998
5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysisD Bentué-Ferrer, J M Reymann, J C Rousselle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 1998
Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levelsS Kõks, E Vasar, A Soosaar, et al.
Neuropeptides|April 3, 1999
Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-mazeS Kõks, A Soosaar, V Võikar, et al.
Therapie|November 1, 1996
[Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]J P Boissel, E Autret, P Bechtel, et al.
Neuropeptides|January 1, 1994
Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-mazeE Vasar, A Lang, J Harro, et al.
Therapie|July 1, 1996
[Study methods of drugs in Alzheimer disease]B Dubois, B Stehlé, J P Lehner, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Rapid gas-chromatographic assay of bupivacaine in plasmaY Le Normand, A Athouel, Y Blanloeil, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Acta Psychiatrica Scandinavica. Supplementum|October 19, 2007
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorderM Berk, S Dodd, M Kauer-Sant'anna, et al.
Acta Psychiatrica Scandinavica. Supplementum|August 18, 2005
A typical mood stabilizers: a "typical role for atypical antipsychoticsG S Malhi, M Berk, M Bourin, et al.
Archives Francaises De Pediatrie|March 1, 1982
[Phenobarbital in the newborn (author's transl)]D Alix, C Riche, Y Guedes, et al.
European Journal of Pharmacology|November 10, 1998
5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysisD Bentué-Ferrer, J M Reymann, J C Rousselle, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 1998
Relation of exploratory behavior of rats in elevated plus-maze to brain receptor binding properties and serum growth hormone levelsS Kõks, E Vasar, A Soosaar, et al.
Neuropeptides|April 3, 1999
Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-mazeS Kõks, A Soosaar, V Võikar, et al.
Therapie|November 1, 1996
[Methodology of preparing a list of educational objectives: example of application to pharmacology. Groupe Objectifs Pédagogiques de L'Association des Enseignants de Pharmacologie]J P Boissel, E Autret, P Bechtel, et al.
Neuropeptides|January 1, 1994
Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-mazeE Vasar, A Lang, J Harro, et al.
Therapie|July 1, 1996
[Study methods of drugs in Alzheimer disease]B Dubois, B Stehlé, J P Lehner, et al.
Fundamental & Clinical Pharmacology|January 1, 1987
Rapid gas-chromatographic assay of bupivacaine in plasmaY Le Normand, A Athouel, Y Blanloeil, et al.
Pageof 17